What is VecTOR Test Systems?
VecTOR Test Systems Inc. is at the forefront of developing specialized diagnostic tests for diseases transmitted by arthropod vectors. Their innovative assay products are designed to detect disease-causing agents within vectors such as mosquitoes, sand flies, and ticks. The company serves health systems and organizations focused on disease surveillance and targeted arthropod control strategies. By providing critical diagnostic tools, VecTOR Test Systems aims to mitigate the significant impact of vector-borne diseases on public health and economies.
How much funding has VecTOR Test Systems raised?
VecTOR Test Systems has raised a total of $35K across 1 funding round:
Debt
$35K
Debt (2021): $35K with participation from PPP
Key Investors in VecTOR Test Systems
PPP
Public-Private Partnership
What's next for VecTOR Test Systems?
With significant Series B/C stage investment, VecTOR Test Systems is poised for accelerated growth and market penetration. The recent capital infusion is expected to fuel the expansion of their product development pipeline and enhance their operational capacity to meet the growing global demand for effective vector-borne disease diagnostics. This strategic financing will likely support increased research and development, broader market outreach, and the scaling of manufacturing capabilities to address critical public health challenges.
See full VecTOR Test Systems company page
